Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl …

M ÅKerlund, A Rødez… - BJOG: An International …, 1993 - Wiley Online Library
Objective To compare two oral contraceptive pills, both containing 150 μg desogestrel, but
with either 20 μg (Mercilon®) or 30 μg (Marvelon®/Desolett®) ethinyl oestradiol (EE) …

Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestoden and desogestrel

KR Petersen, SO Skouby, A Dreisler… - Acta obstetricia et …, 1988 - Taylor & Francis
The effects of two new low-dose oral contraceptives (triphasic ethinyl estradiollgestoden and
monophasic ethinyl estradiolldesogestrel) on glucose tolerance, plasma insulin response to …

Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.

P Bilotta, S Favilli - Arzneimittel-forschung, 1988 - europepmc.org
A multicenter trial was conducted in 267 centers in Italy to evaluate the efficacy, acceptability
and safety of a monophasic oral contraceptive containing 30 micrograms ethinyl estradiol …

Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters

I Wiegratz, C Jung-Hoffmann, W Gross, H Kuhl - Contraception, 1998 - Elsevier
The effect of a triphasic oral contraceptive containing ethinyl estradiol and gestodene
(EE/GSD) on various lipid and lipoprotein parameters was compared with that of a …

A 12-month clinical investigation with a 24-day regimen containing 15 μg ethinylestradiol plus 60 μg gestodene with respect to hemostasis and cycle control

F Fruzzetti, AR Genazzani, C Ricci, F De Negri, C Bersi… - Contraception, 2001 - Elsevier
The effects of a 24-day regimen containing 15 μg ethinyl estradiol (EE) plus 60 μg
gestodene on cycle control and on hemostasis, were evaluated in 58 healthy women (age …

Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.

MR Lepot, UJ Gaspard - International Journal of Fertility, 1987 - europepmc.org
A well-known triphasic oral contraceptive (OC) containing ethinyl estradiol (EE) plus
levonorgestrel (LNG) was compared with a triphasic containing the same dose of EE in …

The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene

N Fuchs, B Düsterberg, F Weber-Diehl, B Mühe - Contraception, 1995 - Elsevier
To obtain an overview of the effect of monophasic gestodene on blood pressure and to
determine the frequency of “OC elevated BP/hypertension,” the results of blood pressure …

Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on …

J Hammerstein, E Daume, A Simon, UH Winkler… - Contraception, 1993 - Elsevier
A randomized controlled clinical trial was undertaken over a 6-month treatment period with
two low-dose combined oral contraceptives (OC) to investigate whether the metabolism and …

New progestogens in oral contraceptives

B Runnebaum, T Rabe - American Journal of Obstetrics and Gynecology, 1987 - Elsevier
The aim of using new synthetic progestogens (gestodene and norgestimate) in oral
hormonal contraceptives is to find a combination that has a more beneficial effect on …

Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.

S Golbs, R Domhardt, S Radowicky… - Methods and findings …, 2002 - europepmc.org
The efficacy and safety of the low dose monophasic oral contraceptive (OC) combination
containing 30 micrograms of ethinylestradiol (EE) and 2.0 mg of dienogest (DNG)(EE/DNG) …